IP Library › Assignment 069271/0596
Patent Assignment
Reel/Frame 069271/0596

Change of Name

Recorded: 2024-10-30 Pages: 38
Assignor
OCULIS OPERATIONS GMBH
Executed: 2023-07-06
Assignee
OCULIS OPERATIONS SÀRL
AVENUE DE LA GARE 39, LAUSANNE, 1003, SWITZERLAND
Covered Properties (6)
Treatment of Ocular Inflammation Following Ocular Surgery
Application: 18/893,790 →
Publication: US 2025/0009757
Stabilized Ophthalmic Dexamethasone Compositions
Application: 18/893,796 →
Publication: US 2025/0009758
Treatment of Ocular Inflammation with Ophthalmic Compositions
Application: 18/893,798 →
Publication: US 2025/0009759
Treatment of Diabetic Retinopathy with Ophthalmic Compositions
Application: 18/893,805 →
Publication: US 2025/0009760
Ph Stabilized Ophthalmic Dexamethasone Compositions
Application: 18/893,806 →
Publication: US 2025/0009761
Ph Stabilized Ophthalmic Compositions
Application: 18/893,810 →
Publication: US 2025/0009762
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 4, 2024
From: LOFTSSON, THORSTEINN; FÜLÖP, ZOLTÁN
To: OCULIS SA
Reel/Frame 068804/0492 →
Merger Oct 4, 2024
From: OCULIS SA
To: OCULIS OPERATIONS GMBH
Reel/Frame 068804/0544 →